Estradiol Valerate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB13956 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 26 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | symptomatic form of fragile X syndrome in female carrier | KG + DL |
| 2 | blepharophimosis-epicanthus inversus-ptosis | KG + DL |
| 3 | partial trisomy/tetrasomy of the short arm of chromosome 5 | KG + DL |
| 4 | partial trisomy/tetrasomy of the short arm of chromosome 12 | KG + DL |
| 5 | blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome | KG + DL |
| 6 | partial trisomy/tetrasomy of the short arm of chromosome 18 | KG + DL |
| 7 | anovulation | KG + DL |
| 8 | ovarian remnant syndrome | KG + DL |
| 9 | luteoma of pregnancy | KG + DL |
| 10 | ovarian dysfunction | KG + DL |
| 11 | partial autosomal trisomy/tetrasomy | KG + DL |
| 12 | ovarian ectopic pregnancy | KG + DL |
| 13 | telecanthus | KG + DL |
| 14 | stapes ankylosis with broad thumbs and toes | KG + DL |
| 15 | 46,XY disorder of sex development due to testicular steroidogenesis defect | KG + DL |
| 16 | longitudinal vaginal septum | KG + DL |
| 17 | transverse vaginal septum | KG + DL |
| 18 | female infertility | KG + DL |
| 19 | ovarian hyperstimulation syndrome | KG + DL |
| 20 | lateral medullary syndrome | KG + DL |
| 21 | ataxia-telangiectasia with generalized skin pigmentation and early death | KG + DL |
| 22 | menstrual cycle-dependent periodic fever | KG + DL |
| 23 | hypogonadism | KG + DL |
| 24 | double outlet right ventricle with atrioventricular septal defect, pulmonary stenosis, heterotaxy | KG + DL |
| 25 | acne (disease) | KG + DL |
| 26 | Waterhouse-Friderichsen syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.